Doximity, Inc. (DOCS)
2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 145,913 | 168,603 | 136,832 | 126,676 |
| Cost of revenue | 15,793 | 14,181 | 13,676 | 13,550 |
| Gross profit | 130,120 | 154,422 | 123,156 | 113,126 |
| Restructuring and impairment charge | - | - | 2,304 | - |
| Sales and marketing | 36,365 | 38,491 | 34,367 | 35,244 |
| Research and development | 26,799 | 22,421 | 23,240 | 22,574 |
| General and administrative | 12,439 | 13,585 | 10,103 | 9,255 |
| Total operating expenses | 75,603 | 74,497 | 70,014 | 67,073 |
| Income from operations | 54,517 | 79,925 | 53,142 | 46,053 |
| Other income, net | 9,630 | - | - | - |
| Other income, net | - | 9,915 | 9,029 | 7,116 |
| Income before income taxes | 64,147 | 89,840 | 62,171 | 53,169 |
| Provision for income taxes | 10,827 | 14,644 | 18,017 | 11,792 |
| Net income | 53,320 | 75,196 | 44,154 | 41,377 |
| Basic (in dollars per share) | 0.28 | 0.4 | 0.24 | 0.22 |
| Basic (in shares) | 187,984,000 | 187,161,000 | 186,252,000 | 185,610,000 |
| Diluted (in dollars per share) | 0.27 | 0.37 | 0.22 | 0.21 |
| Diluted (in shares) | 201,158,000 | 202,233,000 | 200,407,000 | 199,224,000 |